Lundbeck to acquire Chelsea Therapeutics for up to $658 mln

[Reuters] – Danish pharmaceutical company H. Lundbeck said it had entered into a definitive agreement with Chelsea Therapeutics under which it will acquire the U.S. company. Chelsea stockholders are entitled to $6.44 … more

View todays social media effects on CHTP

View the latest stocks trending across Twitter. Click to view dashboard

See who Chelsea is hiring next, click here to view